M. Rouprêt, European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update, Eur. Urol, 2017.

M. Rouprêt,

, Progres En Urol. J. Assoc. Francaise Urol. Soc. Francaise Urol, vol.27, issue.1, pp.67-91, 2016.

M. Yin, Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis, The Oncologist, vol.21, pp.708-715, 2016.

M. Froehner, M. A. Brausi, H. W. Herr, G. Muto, and U. E. Studer, Complications following radical cystectomy for bladder cancer in the elderly, Eur. Urol, vol.56, pp.443-454, 2009.

A. Aziz, Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort, Eur. Urol, vol.66, pp.156-163, 2014.

I. Ziouziou, Ileal conduit vs orthotopic neobladder: Which one offers the best health-related quality of life in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis, Progres En Urol. J. Assoc. Francaise Urol. Soc

F. Urol, , 2018.

P. M. Cawthon, Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults?, J. Am. Geriatr. Soc, vol.57, pp.1411-1419, 2009.

J. Weber, S. Gillain, and J. Petermans,

, Rev. Med. Liege, vol.65, pp.514-520, 2010.

A. J. Cruz-jentoft, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age Ageing, vol.39, pp.412-423, 2010.

J. E. Morley, Sarcopenia in the elderly, Fam. Pract, vol.29, issue.1, pp.44-48, 2012.

M. J. Englesbe, Sarcopenia and mortality after liver transplantation, J. Am. Coll. Surg, vol.211, pp.271-278, 2010.

R. W. Krell, Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation, Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc, vol.19, pp.1396-1402, 2013.

P. D. Peng, Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis, HPB, vol.13, pp.439-446, 2011.

M. S. Sabel, Sarcopenia as a prognostic factor among patients with stage III melanoma, Ann. Surg. Oncol, vol.18, pp.3579-3585, 2011.

F. Shoji, Relationship Between Preoperative Sarcopenia Status and Immunonutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer

, Anticancer Res, vol.37, pp.6997-7003, 2017.

A. B. Smith, Sarcopenia as a predictor of complications and survival following radical cystectomy, J. Urol, vol.191, pp.1714-1720, 2014.

S. P. Psutka, Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality, Cancer, vol.120, pp.2910-2918, 2014.

Y. Hirasawa, Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy, Ann. Surg. Oncol, vol.23, pp.1048-1054, 2016.

R. Mayr, Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer, J. Cachexia Sarcopenia Muscle, 2018.

R. Mayr, Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer, World J. Urol, 2018.

Y. Saitoh-maeda, A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy, BMC Urol, vol.17, p.87, 2017.

R. Kasahara, A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy, BioMed Res. Int, vol.2017, p.7981549, 2017.

L. Martin, Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J. Clin. Oncol. Off. J. Am

. Soc, Clin. Oncol, vol.31, pp.1539-1547, 2013.

M. E. Charlson, P. Pompei, K. L. Ales, and C. R. Mackenzie, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J. Chronic Dis, vol.40, pp.373-383, 1987.

W. D. Owens, J. A. Felts, and E. L. Spitznagel, ASA physical status classifications: a study of consistency of ratings, Anesthesiology, vol.49, pp.239-243, 1978.

D. Dindo, N. Demartines, and P. Clavien, Classification of Surgical Complications, Ann. Surg, vol.240, pp.205-213, 2004.

K. Fearon, Definition and classification of cancer cachexia: an international consensus, Lancet Oncol, vol.12, pp.489-495, 2011.

I. J. Rutten, Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer, J. Cachexia Sarcopenia Muscle, vol.8, pp.630-638, 2017.

F. Wan, Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer, World J. Surg. Oncol, vol.12, p.14, 2014.

B. Detournay, Obesity in France: contribution of the INSEE-CREDES survey on health and medical care, Rev. Epidemiol. Sante Publique, vol.47, pp.385-388, 1999.

S. Payton, Bladder cancer: Sarcopenia predicts cystectomy complications in women, Nat. Rev. Urol, vol.11, p.125, 2014.

H. Ahmadi, Patient Psoas Muscle Mass as a Predictor of Complications and Survival After Radical Cystectomy, Curr. Urol. Rep, vol.16, p.79, 2015.

M. Mourtzakis, A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care, Appl. Physiol. Nutr. Metab. Physiol. Appl. Nutr. Metab, vol.33, pp.997-1006, 2008.

T. Yoshida, Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy, Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med, vol.37, pp.10067-10074, 2016.

T. Hara, Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ? 75 years after radical cystectomy for treatment of bladder cancer, Int. J. Clin. Oncol, vol.21, pp.139-147, 2016.

V. Lohsiriwat, Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgery, World J. Gastroenterol, vol.14, pp.1248-1251, 2008.

S. Studenski, Gait speed and survival in older adults, JAMA, vol.305, p.41, 2011.

H. C. Roberts, A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach, Age Ageing, vol.40, pp.423-429, 2011.

R. Cooper, D. Kuh, and R. Hardy, Mortality Review Group & FALCon and HALCyon Study Teams. Objectively measured physical capability levels and mortality: systematic review and meta-analysis, BMJ, vol.341, p.4467, 2010.

N. Meng, Sarcopenia Defined by Combining Height-and Weight-Adjusted Skeletal Muscle Indices is Closely Associated With Poor Physical Performance, J. Aging Phys. Act, vol.23, pp.597-606, 2015.